English | Español

U.S. Representative Larry Bucshon (in-8)
+ Regulatory
Patient Daily | May 31, 2024

US Reps. Bucshon, Carter, Harshbarger introduce legislation for transparency of 340B drug program
+ Regulatory
Bree Gonzales | Jul 5, 2021

U.S. House bill to close maternal mental health gaps: The problem is 'heartbreaking and it demands action'

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes